The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
The causal relation between human papillomavirus and cervical cancer
Open accessAbstract
The causal role of human papillomavirus infections in cervical cancer has been documented beyond reasonable doubt. The association is present in virtually all cervical cancer cases worldwide. It is the right time for medical societies and public health regulators to consider this evidence and to define its preventive and clinical implications. A comprehensive review of key studies and results is presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,728
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,285
The Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., Shan, K. V., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.11.796 · Cited by 3,370
Self-citationThe human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C.-C., Hwang, L.-Y., & Chien, C.-S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,865
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
Natural History of Cervicovaginal Papillomavirus Infection in Young Women
Ho, G. Y. F., Bierman, R., Beardsley, L., Chang, C. J., & Burk, R. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380703 · Cited by 2,329
Cited by
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
Self-citationPushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Roles of the immune system in cancer: From tumor initiation to metastatic progression
Gonzalez, H., Hagerling, C., & Werb, Z. (2018) · Genes & Development · doi:10.1101/gad.314617.118 · Cited by 2,111
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Harper, D. M., Leodolter, S., Tang, G. W. K., Ferris, D. G., Steben, M., Bryan, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061760 · Cited by 1,886
de Sanjosé, S., Diaz, M., Castellsagué, X., Clifford, G., Bruni, L., Muñoz, N., & Bosch, F. X. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70158-5 · Cited by 1,669
Self-citationHarper, D. M., Franco, E. L., Wheeler, C. M., Moscicki, A.-B., Romanowski, B., Roteli-Martins, C. M., Jenkins, D., Schuind, A., Costa Clemens, S. A., & Dubin, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68439-0 · Cited by 1,632
Dolma, S., Lessnick, S. L., Hahn, W. C., & Stockwell, B. R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00050-3 · Cited by 1,446
Chapter 1: HPV in the etiology of human cancer
Muñoz, N., Castellsagué, X., de González, A. B., & Gissmann, L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.115 · Cited by 1,355
Herrero, R. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg107 · Cited by 1,228
The global burden of women's cancers: a grand challenge in global health
Ginsburg, O., Bray, F., Coleman, M. P., Vanderpuye, V., Eniu, A., Kotha, S. R., Sarker, M., Huong, T. T., Allemani, C., Dvaladze, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31392-7 · Cited by 1,127
Bhatla, N., Aoki, D., Sharma, D. N., & Sankaranarayanan, R. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12611 · Cited by 1,134
Muñoz, N., Bosch, F. X., Castellsagué, X., Díaz, M., de Sanjose, S., Hammouda, D., Shah, K. V., & Meijer, C. J. L. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20244 · Cited by 1,104
Self-citationVaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
Kenter, G. G., Welters, M. J. P., Valentijn, A. R. P. M., Lowik, M. J. G., Berends-van der Meer, D. M. A., Vloon, A. P. G., Essahsah, F., Fathers, L. M., Offringa, R., Drijfhout, J. W., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810097 · Cited by 1,102
Estimates of the global burden of cervical cancer associated with HIV
Stelzle, D., Tanaka, L. F., Lee, K. K., Ibrahim Khalil, A., Baussano, I., Shah, A. S. V., McAllister, D. A., Gottlieb, S. L., Klug, S. J., Winkler, A. S., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30459-9 · Cited by 925
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Arbyn, M., Ronco, G., Anttila, A., Meijer, C. J. L. M., Poljak, M., Ogilvie, G., Koliopoulos, G., Naucler, P., Sankaranarayanan, R., & Peto, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.095 · Cited by 897
Self-citationDoorbar, J. (2005) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.12.006 · Cited by 856
Chapter 1: Human Papillomavirus and Cervical Cancer--Burden and Assessment of Causality
Bosch, F. X., & de Sanjose, S. (2003) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003479 · Cited by 826
Self-citationVilla, L. L., Costa, R. L. R., Petta, C. A., Andrade, R. P., Paavonen, J., Iversen, O.-E., Olsson, S.-E., Høye, J., Steinwall, M., Riis-Johannessen, G., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603469 · Cited by 806
Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer
Naucler, P., Ryd, W., Törnberg, S., Strand, A., Wadell, G., Elfgren, K., Rådberg, T., Strander, B., Johansson, B., Forslund, O., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073204 · Cited by 797
Human Papillomavirus Testing in the Prevention of Cervical Cancer
Schiffman, M., Wentzensen, N., Wacholder, S., Kinney, W., Gage, J. C., & Castle, P. E. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq562 · Cited by 759
Karim-Kos, H. E., de Vries, E., Soerjomataram, I., Lemmens, V., Siesling, S., & Coebergh, J. W. W. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2007.12.015 · Cited by 754
Castellsagué, X., Díaz, M., de Sanjosé, S., Muñoz, N., Herrero, R., Franceschi, S., Peeling, R. W., Ashley, R., Smith, J. S., Snijders, P. J. F., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj067 · Cited by 688
Self-citationThe epidemiology of genital human papillomavirus infection
Trottier, H., & Franco, E. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.09.054 · Cited by 686
Bermudez, A., Bhatla, N., & Leung, E. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2015.06.004 · Cited by 657
Cancer statistics for Hispanics/Latinos, 2012
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21153 · Cited by 655
Arbyn, M., Xu, L., Simoens, C., & Martin-Hirsch, P. P. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009069.pub3 · Cited by 621
Natural history and epidemiology of HPV infection and cervical cancer
Castellsagué, X. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.07.045 · Cited by 590
Parkin, D. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207726 · Cited by 574
Cancer of the cervix uteri: 2021 update
Bhatla, N., Aoki, D., Sharma, D. N., & Sankaranarayanan, R. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13865 · Cited by 554
Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses
Arbyn, M., Sasieni, P., Meijer, C. J. L. M., Clavel, C., Koliopoulos, G., & Dillner, J. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.117 · Cited by 539
Self-citationProjected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine
Goldie, S. J., Kohli, M., Grima, D., Weinstein, M. C., Wright, T. C., Bosch, F. X., & Franco, E. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh104 · Cited by 539
Self-citationA review of current evidence for the causal impact of attentional bias on fear and anxiety
Van Bockstaele, B., Verschuere, B., Tibboel, H., De Houwer, J., Crombez, G., & Koster, E. H. W. (2014) · Psychological Bulletin · doi:10.1037/a0034834 · Cited by 485
Wright, T. C., Schiffman, M., Solomon, D., Cox, J. T., Garcia, F., Goldie, S., Hatch, K., Noller, K. L., Roach, N., Runowicz, C., et al. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000109426.82624.f8 · Cited by 499
GIANNINI, S., HANON, E., MORIS, P., VANMECHELEN, M., MOREL, S., DESSY, F., FOURNEAU, M., COLAU, B., SUZICH, J., & LOSONKSY, G. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.005 · Cited by 496
Cytology versus HPV testing for cervical cancer screening in the general population
Koliopoulos, G., Nyaga, V. N., Santesso, N., Bryant, A., Martin-Hirsch, P. P., Mustafa, R. A., Schünemann, H., Paraskevaidis, E., & Arbyn, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008587.pub2 · Cited by 494
Bead-Based Multiplex Genotyping of Human Papillomaviruses
Schmitt, M., Bravo, I. G., Snijders, P. J. F., Gissmann, L., Pawlita, M., & Waterboer, T. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.2.504-512.2006 · Cited by 482
GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives
Garçon, N., Chomez, P., & Van Mechelen, M. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.5.723 · Cited by 476
Integration of high‐risk human papillomavirus: a key event in cervical carcinogenesis?
Pett, M., & Coleman, N. (2007) · The Journal of Pathology · doi:10.1002/path.2192 · Cited by 451
The carcinogenicity of human papillomavirus types reflects viral evolution
Schiffman, M., Herrero, R., DeSalle, R., Hildesheim, A., Wacholder, S., Cecilia Rodriguez, A., Bratti, M. C., Sherman, M. E., Morales, J., Guillen, D., et al. (2005) · Virology · doi:10.1016/j.virol.2005.04.002 · Cited by 441
Dalstein, V., Riethmuller, D., Prétet, J., Le Bail Carval, K., Sautière, J., Carbillet, J., Kantelip, B., Schaal, J., & Mougin, C. (2003) · International Journal of Cancer · doi:10.1002/ijc.11222 · Cited by 435
Prophylactic human papillomavirus vaccines
Lowy, D. R. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28607 · Cited by 428
Koshiol, J., Lindsay, L., Pimenta, J. M., Poole, C., Jenkins, D., & Smith, J. S. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn036 · Cited by 428
The Epidemiology and Risk Factors of Head and Neck Cancer: a Focus on Human Papillomavirus
Ragin, C. C. R., Modugno, F., & Gollin, S. M. (2007) · Journal of Dental Research · doi:10.1177/154405910708600202 · Cited by 416
Prevention of cervical cancer through papillomavirus vaccination
Frazer, I. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1260 · Cited by 402
Einstein, M. H., Baron, M., Levin, M. J., Chatterjee, A., Edwards, R. P., Zepp, F., Carletti, I., Dessy, F. J., Trofa, A. F., Schuind, A., et al. (2009) · Human Vaccines · doi:10.4161/hv.5.10.9518 · Cited by 402
Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries
Bray, F., Carstensen, B., Møller, H., Zappa, M., Žakelj, M. P., Lawrence, G., Hakama, M., & Weiderpass, E. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0231 · Cited by 393
Historical review of the causes of cancer
Blackadar, C. B. (2016) · World Journal of Clinical Oncology · doi:10.5306/wjco.v7.i1.54 · Cited by 389
Welters, M. J. P., Kenter, G. G., Piersma, S. J., Vloon, A. P. G., Löwik, M. J. G., Berends-van der Meer, D. M. A., Drijfhout, J. W., Valentijn, A. R. P. M., Wafelman, A. R., Oostendorp, J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1880 · Cited by 373
Bray, F., Loos, A. H., McCarron, P., Weiderpass, E., Arbyn, M., Møller, H., Hakama, M., & Parkin, D. M. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0569 · Cited by 370
Screening-Preventable Cervical Cancer Risks: Evidence From a Nationwide Audit in Sweden
Andrae, B., Kemetli, L., Sparen, P., Silfverdal, L., Strander, B., Ryd, W., Dillner, J., & Tornberg, S. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn099 · Cited by 363
Oral Human Papillomavirus Infection in Adults Is Associated with Sexual Behavior and HIV Serostatus
Kreimer, A. R., Alberg, A. J., Daniel, R., Gravitt, P. E., Viscidi, R., Garrett, E. S., Shah, K. V., & Gillison, M. L. (2004) · The Journal of Infectious Diseases · doi:10.1086/381504 · Cited by 361
Self-citationArbyn, M., Buntinx, F., Ranst, M. V., Paraskevaidis, E., Martin-Hirsch, P., & Dillner, J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh037 · Cited by 359
The Epidemiology of Human Papillomavirus Infection and Cervical Cancer
Bosch, F. X., & de Sanjosé, S. (2007) · Disease Markers · doi:10.1155/2007/914823 · Cited by 357
Self-citationHuman Papillomavirus Infections with Multiple Types and Risk of Cervical Neoplasia
Trottier, H., Mahmud, S., Costa, M. C., Sobrinho, J. P., Duarte-Franco, E., Rohan, T. E., Ferenczy, A., Villa, L. L., & Franco, E. L. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0129 · Cited by 352
An Armamentarium of Wart Treatments
Lipke, M. M. (2006) · Clinical Medicine & Research · doi:10.3121/cmr.4.4.273 · Cited by 344
Schlecht, N. F. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg037 · Cited by 338
Termine, N., Panzarella, V., Falaschini, S., Russo, A., Matranga, D., Lo Muzio, L., & Campisi, G. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn372 · Cited by 337
Quadrivalent Human Papillomavirus Vaccine
Gellin, B., Modlin, J. F., Barr, E., & Tamms, G. (2007) · Clinical Infectious Diseases · doi:10.1086/520654 · Cited by 330
Human Papillomavirus Infection and the Multistage Carcinogenesis of Cervical Cancer
Schiffman, M., & Wentzensen, N. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1406 · Cited by 324
Epidemiology of head and neck cancer: Magnitude of the problem
D�br�ssy, L. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-5044-4 · Cited by 321
Brusselaers, N., Shrestha, S., van de Wijgert, J., & Verstraelen, H. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.12.011 · Cited by 317
Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
Garçon, N., & Van Mechelen, M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.29 · Cited by 314
Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers
Mezache, L., Paniccia, B., Nyinawabera, A., & Nuovo, G. J. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.108 · Cited by 311
European Code Against Cancer and scientific justification: third version (2003)
Boyle, P., Autier, P., Bartelink, H., Baselga, J., Boffetta, P., Burn, J., Burns, H. J. G., Christensen, L., Denis, L., Dicato, M., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg305 · Cited by 308
Human papillomavirus infection: Epidemiology and pathophysiology
Steben, M., & Duarte-Franco, E. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.07.067 · Cited by 307
Melnikow, J., Henderson, J. T., Burda, B. U., Senger, C. A., Durbin, S., & Weyrich, M. S. (2018) · JAMA · doi:10.1001/jama.2018.10400 · Cited by 302
Environmental co-factors in HPV carcinogenesis
Castellsagué, X., Bosch, F. X., & Muñoz, N. (2002) · Virus Research · doi:10.1016/s0168-1702(02)00188-0 · Cited by 301
Self-citationShrestha, A. D., Neupane, D., Vedsted, P., & Kallestrup, P. (2018) · PubMed · doi:10.22034/apjcp.2018.19.2.319 · Cited by 295
Understanding and learning from the success of prophylactic human papillomavirus vaccines
Schiller, J. T., & Lowy, D. R. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2872 · Cited by 293
Cancer statistics for African Americans, 2013
DeSantis, C., Naishadham, D., & Jemal, A. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21173 · Cited by 291
Roura, E., Castellsagué, X., Pawlita, M., Travier, N., Waterboer, T., Margall, N., Bosch, F. X., de Sanjosé, S., Dillner, J., Gram, I. T., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28666 · Cited by 283
Self-citationHow will HPV vaccines affect cervical cancer?
Roden, R., & Wu, T.-C. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1973 · Cited by 283
Gerend, M. A., & Magloire, Z. F. (2008) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2007.08.022 · Cited by 283
Using message framing to promote acceptance of the human papillomavirus vaccine.
Gerend, M. A., & Shepherd, J. E. (2007) · Health Psychology · doi:10.1037/0278-6133.26.6.745 · Cited by 283
for the International Agency for Research on Cancer Multicenter Cervical Cancer Study Group, Louie, K. S., de Sanjose, S., Diaz, M., Castellsagué, X., Herrero, R., Meijer, C. J., Shah, K., Franceschi, S., Muñoz, N., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604974 · Cited by 280
Self-citationOgilvie, G. S., van Niekerk, D., Krajden, M., Smith, L. W., Cook, D., Gondara, L., Ceballos, K., Quinlan, D., Lee, M., Martin, R. E., et al. (2018) · JAMA · doi:10.1001/jama.2018.7464 · Cited by 279
Snijders, P. J., van den Brule, A. J., & Meijer, C. J. (2003) · The Journal of Pathology · doi:10.1002/path.1433 · Cited by 278
Self-citationBulkmans, N. W. J., Rozendaal, L., Snijders, P. J. F., Voorhorst, F. J., Boeke, A. J. P., Zandwijken, G. R. J., van Kemenade, F. J., Verheijen, R. H. M., v Groningen, K., Boon, M. E., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20076 · Cited by 269
Self-citationHuman Papillomavirus-DNA Loads in Actinic Keratoses Exceed those in Non-Melanoma Skin Cancers
Weissenborn, S. J., Nindl, I., Purdie, K., Harwood, C., Proby, C., Breuer, J., Majewski, S., Pfister, H., & Wieland, U. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23733.x · Cited by 265
Key Molecular Events in Cervical Cancer Development
Balasubramaniam, S. D., Balakrishnan, V., Oon, C. E., & Kaur, G. (2019) · Medicina · doi:10.3390/medicina55070384 · Cited by 263
Natural History of HPV Infection across the Lifespan: Role of Viral Latency
Gravitt, P., & Winer, R. (2017) · Viruses · doi:10.3390/v9100267 · Cited by 262
Human papillomavirus infection: biology, epidemiology, and prevention
SCHEURER, M. E., TORTOLERO-LUNA, G., & ADLER-STORTHZ, K. (2005) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2005.00246.x · Cited by 260
Louie, K. S., De Sanjose, S., & Mayaud, P. (2009) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2009.02372.x · Cited by 260
Diagnoses and outcomes in cervical cancer screening: A population-based study
Insinga, R. P., Glass, A. G., & Rush, B. B. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.01.043 · Cited by 259
Mitra, A., MacIntyre, D. A., Ntritsos, G., Smith, A., Tsilidis, K. K., Marchesi, J. R., Bennett, P. R., Moscicki, A.-B., & Kyrgiou, M. (2020) · Nature Communications · doi:10.1038/s41467-020-15856-y · Cited by 257
Koliopoulos, G., Arbyn, M., Martin-Hirsch, P., Kyrgiou, M., Prendiville, W., & Paraskevaidis, E. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.08.053 · Cited by 254
Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses
Orth, G. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.07.008 · Cited by 249
Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer
Lõhmussaar, K., Oka, R., Espejo Valle-Inclan, J., Smits, M. H. H., Wardak, H., Korving, J., Begthel, H., Proost, N., van de Ven, M., Kranenburg, O. W., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.03.012 · Cited by 211
Sankaranarayanan, R., Nene, B. M., Dinshaw, K. A., Mahe, C., Jayant, K., Shastri, S. S., Malvi, S. G., Chinoy, R., Kelkar, R., Budukh, A. M., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21050 · Cited by 233
Coutlée, F., Rouleau, D., Petignat, P., Ghattas, G., Kornegay, J. R., Schlag, P., Boyle, S., Hankins, C., Vézina, S., Coté, P., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00104-06 · Cited by 186
Multiparameter calibration of a natural history model of cervical cancer
Kim, J. J., Kuntz, K. M., Stout, N. K., Mahmud, S., Villa, L. L., Franco, E. L., & Goldie, S. J. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm086 · Cited by 161
McSherry, L. A., Dombrowski, S. U., Francis, J. J., Murphy, J., Martin, C. M., O’Leary, J. J., Sharp, L., & ATHENS Group (2012) · Implementation Science · doi:10.1186/1748-5908-7-73 · Cited by 129
Verhoeven, V., Renard, N., Makar, A., Royen, P. V., Bogers, J.-P., Lardon, F., Peeters, M., & Baay, M. (2013) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e328355ed23 · Cited by 135
Palma, E., Recine, N., Domenici, L., Giorgini, M., Pierangeli, A., & Panici, P. B. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-017-2938-z · Cited by 132
Sankaranarayanan, R., Chatterji, R., Shastri, S. S., Wesley, R. S., Basu, P., Mahe, C., Muwonge, R., Seigneurin, D., Somanathan, T., Roy, C., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20396 · Cited by 127
Fesenfeld, M., Hutubessy, R., & Jit, M. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.06.060 · Cited by 123
Global Proficiency Study of Human Papillomavirus Genotyping
Eklund, C., Zhou, T., & Dillner, J. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00918-10 · Cited by 122
Vaccines to Prevent Infections by Oncoviruses
Schiller, J. T., & Lowy, D. R. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134019 · Cited by 101
Lu, Z., Hu, X., Li, Y., Zheng, L., Zhou, Y., Jiang, H., Ning, T., Basang, Z., Zhang, C., & Ke, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403385200 · Cited by 96
Metadata
- Authors
- Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J. L. M., & Shah, K. V.
- Venue
- Journal of Clinical Pathology
- Publisher
- BMJ
- Published
- 2002-04-01
- Volume
- 55
- Issue
- 4
- Pages
- 244-265
- ISSN
- 0021-9746 (ISSN-L)
- OpenAlex
- W2114813165
- Cited by
- 3,538
- References
- 215
- FWCI
- 86.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.